News

While the mortality rate for breast cancer in the U.S. has significantly declined from its peak in 1989, incidence among younger women has steadily increased each year since 2001, according to the American Cancer Society.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

According to the National Cancer Institute, about 40% of women have dense breast tissue, which makes it more difficult to find breast cancer early.

Dr. Mary Mitchell, chief of breast radiology at Saint Luke's, talks to KSHB about what dense breast tissue is and how it impacts your risk of developing breast cancer.

We are talking with Marji Stark, lactation consultant at Saint Luke’s East Hospital, about the breastfeeding journey for mothers who have prematurely given birth to their babies.

Feeling “off” turned into a critical situation within moments when Stacee suffered a ruptured brain aneurysm that led to a hemorrhagic stroke.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

An elementary school music teacher and jazz musician, 54-year-old Lisa was initially diagnosed with high blood pressure—the number one killer of women—in her early 30s. It is often called “the silent killer” because most who have it don’t experience any symptoms. Lisa was on blood pressure medication but had stopped taking it because she experienced side effects. She put off seeing her doctor about it for several months.